Table 3 Univariate and multivariate analysis of TyG index and LVEF < 40%.
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
OR (95%CI) | P value | OR (95%CI) | P value | |
Age | 1.026 (1.004–1.049) | 0.020 | 1.012 (0.986–1.038) | 0.376 |
Male | 1.371 (0.812–2.317) | 0.238 | ||
SBP | 0.979 (0.968–0.991) | 0.001 | 0.983 (0.970–0.996) | 0.012 |
DBP | 0.985 (0.967–1.003) | 0.104 | ||
RHR | 1.020 (1.007–1.034) | 0.002 | 1.014 (1.000–1.029) | 0.055 |
Ischemic time | 1.000 (0.999–1.003) | 0.734 | ||
WBC | 1.014 (0.982–1.046) | 0.401 | ||
Hb | 0.984 (0.973–0.995) | 0.005 | 0.992 (0.979–1.005) | 0.248 |
TyG | 1.019 (0.695–1.494) | 0.924 | ||
FBG | 1.084 (1.026–1.146) | 0.004 | 1.016 (0.937–1.102) | 0.702 |
TG | 0.598 (0.410–0.873) | 0.008 | 0.652 (0.429–0.992) | 0.046 |
BUN | 1.240 (1.144–1.343) | < 0.001 | 1.127 (0.996–1.275) | 0.058 |
Creatinine | 1.018 (1.009–1.027) | < 0.001 | 1.002 (0.989–1.015) | 0.790 |
LDL-C | 1.018 (0.744–1.392) | 0.911 | ||
HDL-C | 1.765 (0.844–3.694) | 0.131 | ||
TC | 1.050 (0.840–1.313) | 0.666 | ||
UA | 1.002 (1.000–1.004) | 0.012 | 1.000 (0.999–1.002) | 0.651 |
ApoA1 | 1.597 (0.541–4.715) | 0.396 | ||
ApoB | 1.594 (0.608–4.181) | 0.343 | ||
Lp(a) | 1.000 (0.999–1.001) | 0.954 | ||
LAD as IRA | 2.677 (1.548–4.628) | < 0.001 | 2.452 (1.352–4.449) | 0.003 |
Extent of coronary artery disease | ||||
1-vessel | 1 | – | 1 | – |
2-vessel | 1.94 (0.903–4.167) | 0.089 | 1.545 (0.686–3.481) | 0.294 |
3-vessel | 2.463 (1.209–5.018) | 0.013 | 1.266 (0.540–2.969) | 0.587 |
Gensini score | 1.012 (1.007–1.017) | < 0.001 | 1.009 (1.003–1.016) | 0.003 |
Hypertension | 0.814 (0.509–1.302) | 0.390 | ||
Diabetes mellitus | 1.875 (1.147–3.063) | 0.012 | 0.919 (0.399–2.119) | 0.843 |
Dyslipidemia | 1.617 (0.988–2.648) | 0.056 | ||
Current Smoking | 1.326 (0.818–2.149) | 0.253 | ||
Atrial fibrillation | 1.074 (0.317–3.640) | 0.909 | ||
Family history of CAD | 1.339 (0.456–3.933) | 0.595 | ||
Family history of cerebrovascular disease | 1.941 (1.121–3.361) | 0.018 | 1.378 (0.419–4.530) | 0.598 |
Serum AP level Tertile | ||||
I (low) | 1 | – | 1 | – |
II (middle) | 1.529 (0.809–2.893) | 0.191 | 1.857 (0.920–3.750) | 0.084 |
III (high) | 2.198 (1.197–4.036) | 0.011 | 2.598 (1.331–5.071) | 0.005 |
Antiplatelets | 2.580 (0.930–7.153) | 0.069 | ||
Beta-blocker | 0.770 (0.178–3.330) | 0.726 | ||
Calcium inhibitor | 0.649 (0.349–1.207) | 0.172 | ||
ACEI | – | 0.998 | ||
Angiotensin II antagonist | 0.712 (0.214–2.367) | 0.580 | ||
Diuretic | 2.263 (0.472–10.851) | 0.307 | ||
Insulin | 1.421 (0.537–3.760) | 0.479 | ||
Oral antidiabetic drug | 2.137 (1.173–3.892) | 0.013 | 1.779 (0.722–4.387) | 0.211 |
Statin | 2.736 (0.981–7.632) | 0.055 | ||
Atrial fibrillation | 1.074 (0.317–3.640) | 0.909 | ||
Ventricular Tachycardia | 2.59 (0.529–12.692) | 0.240 | ||
Heart arrest | 3.026 (0.600–15.258) | 0.180 | ||
Pulmonary Infection | 2.189 (0.928–5.164) | 0.074 | ||
Hydropericardium | 1.795 (0.207–15.562) | 0.596 | ||